The evolution of TB treatment in India

"... the need of the hour is to expand access to treatment for the most vulnerable subset of multidrug-resistant TB patients and ensure the judicious use of antibiotics in the public and private sector, while maintaining the level of funding required to tackle the growing threat of drug-resistant TB."

To read the full article, click here.

To subscribe to the Weekly Newsletter of new posts, enter your email here:


By Mohit Nair

Published: Jan. 9, 2019, 9:17 p.m.

Last updated: Jan. 9, 2019, 11:49 p.m.

Print Share